Literature DB >> 33153669

Pediatric Thyroid Cancer: Genetics, Therapeutics and Outcome.

Andrew J Bauer1.   

Abstract

An increasing number of children are diagnosed with thyroid cancer. Most patients do not have an identifiable cause; however, tumor predisposition syndromes may be associated with development of both differentiated and medullary thyroid cancer. With an excellent prognosis for most patients, the goal of therapy is to optimize outcome and reduce complications. The increased knowledge of the oncogenic drivers provides opportunities to improve the accuracy of diagnosis, stratify surgery, and select systemic therapy that may be considered for neoadjuvant and adjuvant treatment. Treatment complications can be reduced by referral to regional, high-volume pediatric thyroid centers.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adolescent; Child; Follicular; Medullary; Papillary; Pediatric; Thyroid cancer; Thyroid nodule

Year:  2020        PMID: 33153669     DOI: 10.1016/j.ecl.2020.08.001

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  8 in total

Review 1.  The clinical aspect of NTRK-fusions in pediatric papillary thyroid cancer.

Authors:  Julio C Ricarte-Filho; Stephen Halada; Alison O'Neill; Victoria Casado-Medrano; Theodore W Laetsch; Aime T Franco; Andrew J Bauer
Journal:  Cancer Genet       Date:  2022-01-19

2.  Fusion Oncogenes Are Associated With Increased Metastatic Capacity and Persistent Disease in Pediatric Thyroid Cancers.

Authors:  Aime T Franco; Julio C Ricarte-Filho; Amber Isaza; Zachary Jones; Neil Jain; Sogol Mostoufi-Moab; Lea Surrey; Theodore W Laetsch; Marilyn M Li; Jessica Clague DeHart; Erin Reichenberger; Deanne Taylor; Ken Kazahaya; N Scott Adzick; Andrew J Bauer
Journal:  J Clin Oncol       Date:  2022-01-11       Impact factor: 50.717

3.  The Clinical Spectrum of PTEN Hamartoma Tumor Syndrome: Exploring the Value of Thyroid Surveillance.

Authors:  Julia A Baran; Steven D Tsai; Amber Isaza; Garrett M Brodeur; Suzanne P MacFarland; Kristin Zelley; Denise M Adams; Aime T Franco; Andrew J Bauer
Journal:  Horm Res Paediatr       Date:  2021-04-22       Impact factor: 2.852

4.  Oncogene-specific inhibition in the treatment of advanced pediatric thyroid cancer.

Authors:  Aime T Franco; Julio C Ricarte-Filho; Theodore W Laetsch; Andrew J Bauer
Journal:  J Clin Invest       Date:  2021-09-15       Impact factor: 19.456

5.  High Incidence of Distant Metastasis Is Associated With Histopathological Subtype of Pediatric Papillary Thyroid Cancer - a Retrospective Analysis Based on SEER.

Authors:  Xue Zeng; Zhihong Wang; Zhiqiang Gui; Jingzhe Xiang; Mengsu Cao; Wei Sun; Liang He; Wenwu Dong; Jiapeng Huang; Dalin Zhang; Chengzhou Lv; Ting Zhang; Liang Shao; Ping Zhang; Hao Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-11       Impact factor: 5.555

6.  Clinical Application Value of High-Frequency Ultrasound Combined with Detection of Serum High Mobility Group Box 1, Soluble IL-2 Receptor, and Thyroglobulin Antibody in Diagnosing Thyroid Cancer.

Authors:  Ning Li; Jiahui Zhang; Xiaojiao Meng; Wenliang Yao
Journal:  J Healthc Eng       Date:  2022-03-29       Impact factor: 2.682

7.  Germline pathogenic variants in cancer risk genes among patients with thyroid cancer and suspected predisposition.

Authors:  Junne Kamihara; Jing Zhou; Holly LaDuca; Ari J Wassner; Emily Dalton; Judy E Garber; Mary Helen Black
Journal:  Cancer Med       Date:  2022-02-17       Impact factor: 4.711

8.  Predictive factors of malignancy in pediatric patients with thyroid nodules and performance of the Italian classification (SIAPEC 2014) in the outcome of the cytological FNA categories.

Authors:  Gerdi Tuli; Jessica Munarin; Erica Agosto; Patrizia Matarazzo; Francesco Quaglino; Alberto Mormile; Luisa de Sanctis
Journal:  Endocrine       Date:  2021-06-14       Impact factor: 3.633

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.